Abstract
The pandemic of coronavirus disease 2019 (COVID-19) has become a threat to human life and society. Scientists and clinicians are struggling with the intrusive SARS-CoV-2 virus to enhance their knowledge about its pathogenesis and find an effective medicine and vaccine to combat its complications. Till now, they have learned that this SARS-CoV-2 has not infected all people exposed to this virus, and also severe respiratory illnesses have not been observed in all infected patients. Patients over 65 or with underlying diseases are more vulnerable to develop severe disease. Based on this premise, a highly challenging question is why some people are more susceptible to this virus and others are not. The present study was aimed to review the current information, which explains the broad spectrum of COVID-19 presentation. Here, we discussed how genetic background, immune system, underlying disease, smoking status, as well as age, race, and gender affect COVID-19 susceptibility.
Keywords: COVID-19, SARS-CoV-2, Age, Race, Gender, Smoking status, Genetic susceptibility, Immune system, Underlying diseases.
Current Molecular Medicine
Title:Do Genetic Factors Predispose People to COVID-19: A Review Article
Volume: 21 Issue: 6
Author(s): Ava Nasrolahi, Karimeh Haghani, Ali Gheysarzadeh and Salar Bakhtiyari*
Affiliation:
- Department of Clinical Biochemistry, School of Medicine, Ilam University of Medical Sciences, Ilam,Iran
Keywords: COVID-19, SARS-CoV-2, Age, Race, Gender, Smoking status, Genetic susceptibility, Immune system, Underlying diseases.
Abstract: The pandemic of coronavirus disease 2019 (COVID-19) has become a threat to human life and society. Scientists and clinicians are struggling with the intrusive SARS-CoV-2 virus to enhance their knowledge about its pathogenesis and find an effective medicine and vaccine to combat its complications. Till now, they have learned that this SARS-CoV-2 has not infected all people exposed to this virus, and also severe respiratory illnesses have not been observed in all infected patients. Patients over 65 or with underlying diseases are more vulnerable to develop severe disease. Based on this premise, a highly challenging question is why some people are more susceptible to this virus and others are not. The present study was aimed to review the current information, which explains the broad spectrum of COVID-19 presentation. Here, we discussed how genetic background, immune system, underlying disease, smoking status, as well as age, race, and gender affect COVID-19 susceptibility.
Export Options
About this article
Cite this article as:
Nasrolahi Ava , Haghani Karimeh , Gheysarzadeh Ali and Bakhtiyari Salar *, Do Genetic Factors Predispose People to COVID-19: A Review Article, Current Molecular Medicine 2021; 21 (6) . https://dx.doi.org/10.2174/1566524020999201113102145
DOI https://dx.doi.org/10.2174/1566524020999201113102145 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
An Overview on COVID-19: Clinical Features, Treatment and Prevention
Coronaviruses Non-Respiratory Manifestations of COVID-19 and Pathophysiological Evidences
New Emirates Medical Journal Flu Viral Multiplex Testing and its Implication for COVID-19 Testing
New Emirates Medical Journal Therapies of Hematological Malignancies: An Overview of the Potential Targets and Their Inhibitors
Current Chemical Biology Potential Mitigation, Prophylactics, and Treatments to Overcome COVID- 19
Coronaviruses A Mini-review of Computational Approaches to Predict Functions and Findings of Novel Micro Peptides
Current Bioinformatics SARS Coronavirus Anti-Infectives
Recent Patents on Anti-Infective Drug Discovery Angiotensin Converting Enzyme-2: A Doorway for SARS-CoV-2
Coronaviruses The Outbreak of Novel Coronavirus-a New Type of Threat in 2020: Genesis, Detection, Treatment, and Management
Coronaviruses Phytochemical Informatics and Virtual Screening of Herbs Used in Chinese Medicine
Current Pharmaceutical Design Prevention of COVID-19 Infection in the Medical Population: Possible Help from Anosmia?
Reviews on Recent Clinical Trials Efficacy of Lopinavir/Ritonavir Compared With Standard Care for Treatment of Coronavirus Disease 2019 (COVID-19): A Systematic Review
Infectious Disorders - Drug Targets COVID-19 Pandemic: Care for Indian Cancer Patients
Coronaviruses Novel Corona-Virus Disease 2019 (COVID-19): A Perilous Life- Threatening Epidemic
Coronaviruses A Note on Estimating the Case Fatality Ratio for Novel Corona Virus Disease (COVID-19)
Coronaviruses Potential Inhibition of COVID-19 RNA-dependent RNA Polymerase by Hepatitis C Virus Non-nucleoside Inhibitors: An <i>In-silico</i> Perspective
Letters in Drug Design & Discovery Characterization of Proteins from Putative Human DNA and RNA Viruses
Current Proteomics Challenges of Covid-19 on Adolescent Psychiatric Service Provision in an Independent Inpatient and Outpatient Setting
Adolescent Psychiatry Neutralization of SARS-CoV-2 Spike Protein via Natural Compounds: A Multilayered High Throughput Virtual Screening Approach
Current Pharmaceutical Design SARS-CoV-2 Spread Dynamics in Italy: The Calabria Experience
Reviews on Recent Clinical Trials